RE: Additional sampling and improved CV results30 Sep 2021 08:37
sounds like its going quite well
Early challenges with the supply chain were quickly resolved and the commercial roll-out of the AffiDX® SARS-CoV-2 antigen lateral flow test is progressing both through direct sales and through distributors. Avacta’s direct sales efforts are focused on large businesses, primarily but not exclusively in the UK, for workforce testing and on a range of other users of professional use tests such as elite professional sports teams and the travel industry. Commercial traction is building driven by the key benefits of the test previously described.